Anti-SYMPK/ SPK/ SYM monoclonal antibody

Anti-SYMPK/ SPK/ SYM antibody for FACS & in-vivo assay

Target products collectionGo to SYMPK/SYMPK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2343-Ab-1/ GM-Tg-hg-MP2343-Ab-2Anti-Human SYMPK monoclonal antibodyHuman
GM-Tg-rg-MP2343-Ab-1/ GM-Tg-rg-MP2343-Ab-2Anti-Rat SYMPK monoclonal antibodyRat
GM-Tg-mg-MP2343-Ab-1/ GM-Tg-mg-MP2343-Ab-2Anti-Mouse SYMPK monoclonal antibodyMouse
GM-Tg-cynog-MP2343-Ab-1/ GM-Tg-cynog-MP2343-Ab-2Anti-Cynomolgus/ Rhesus macaque SYMPK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2343-Ab-1/ GM-Tg-felg-MP2343-Ab-2Anti-Feline SYMPK monoclonal antibodyFeline
GM-Tg-cang-MP2343-Ab-1/ GM-Tg-cang-MP2343-Ab-2Anti-Canine SYMPK monoclonal antibodyCanine
GM-Tg-bovg-MP2343-Ab-1/ GM-Tg-bovg-MP2343-Ab-2Anti-Bovine SYMPK monoclonal antibodyBovine
GM-Tg-equg-MP2343-Ab-1/ GM-Tg-equg-MP2343-Ab-2Anti-Equine SYMPK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2343-Ab-1/ GM-Tg-hg-MP2343-Ab-2; GM-Tg-rg-MP2343-Ab-1/ GM-Tg-rg-MP2343-Ab-2;
GM-Tg-mg-MP2343-Ab-1/ GM-Tg-mg-MP2343-Ab-2; GM-Tg-cynog-MP2343-Ab-1/ GM-Tg-cynog-MP2343-Ab-2;
GM-Tg-felg-MP2343-Ab-1/ GM-Tg-felg-MP2343-Ab-2; GM-Tg-cang-MP2343-Ab-1/ GM-Tg-cang-MP2343-Ab-2;
GM-Tg-bovg-MP2343-Ab-1/ GM-Tg-bovg-MP2343-Ab-2; GM-Tg-equg-MP2343-Ab-1/ GM-Tg-equg-MP2343-Ab-2
Products NameAnti-SYMPK monoclonal antibody
Formatmab
Target NameSYMPK
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SYMPK benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SYMPK/ SPK/ SYM VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2343
    Target NameSYMPK
    Gene ID8189,68188,292683,722436,476431,101092974,100337373,100070949
    Gene Symbol and Synonyms1500016F02Rik,4632415H16Rik,Hfn3g,Pta1,SPK,SYM,SYMPK
    Uniprot AccessionQ92797
    Uniprot Entry NameSYMPK_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125755
    Target ClassificationN/A

    The target: SYMPK, gene name: SYMPK, also named as SPK, SYM. This gene encodes a nuclear protein that functions in the regulation of polyadenylation and promotes gene expression. The protein forms a high-molecular weight complex with components of the polyadenylation machinery. It is thought to serve as a scaffold for recruiting regulatory factors to the polyadenylation complex. It also participates in 3'-end maturation of histone mRNAs, which do not undergo polyadenylation. The protein also localizes to the cytoplasmic plaques of tight junctions in some cell types. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.